Goodwin

Heath Ingram

Deals
4
Latest
May 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 4 deals
Deals by year
Heath Ingram: deals by year0123420252026 YTD: 4 M&A42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Heath Ingram was named on, most recent first
May 2026 LimmaTech Biologics AG –Eli Lilly and CompanyAcquisitionLegal adviser to LimmaTech Biologics AG (target)Pending780.0BiotechEli Lilly and Company acquisition of LimmaTech Biologics AG
Apr 2026 CathWorks –MedtronicAcquisitionLegal adviser to CathWorks (target)Announced585.0Medtech+1Medtronic acquisition of CathWorks
Apr 2026 Worldwide rights to Kenalog Bristol-Myers SquibbSubsidiary of Piramal PharmaAsset saleLegal adviser to subsidiary of Piramal Pharma (acquirer)Announced35.0PharmaSubsidiary of Piramal Pharma acquisition of Worldwide rights to Kenalog
Mar 2026 Pikavation SynnovationNovartisAcquisitionLegal adviser to Synnovation Therapeutics (seller)Announced2,000.0Biotech+2Novartis acquisition of Pikavation

Deals where Heath Ingram is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.